Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
25.05
+0.84 (3.47%)
At close: Oct 30, 2026, 4:00 PM EDT
25.74
+0.69 (2.75%)
After-hours: Oct 30, 2026, 7:59 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.2 billion as of October 30, 2026. It is the 8,922nd most valuable company in the world and the 2,110th biggest in the United States. Its market cap has decreased by 4.84% in one year.
Market Cap
1.20B
Enterprise Value
775.88M
1-Year Change
-4.84%
Global Rank
Country Rank
#2,110 United States
Category
ChartMarket Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.20B, an increase of 99.84%. That is a compound annual growth rate of 33.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.20B | -16.89% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kardigan | 1.32B |
| LB Pharmaceuticals | 1.28B |
| Ascentage Pharma Group International | 1.27B |
| Savara | 1.22B |
| Syndax Pharmaceuticals | 1.22B |
| Alpha Tau Medical | 1.21B |
| Silence Therapeutics | 1.19B |
| Verastem | 1.18B |